
TRIPLE THERAPY WITH DPP4 INHIBITOR, INSULIN, OR THIAZOLIDINEDIONES AND RISKS OF CARDIOVASCULAR DISEASES AND ALL-CAUSE MORTALITY IN PATIENTS WITH FAILED METFORMIN-SU THERAPY
Author(s) -
Carlos King Ho Wong,
Yujian Shi,
ChungShun Ho,
Eric Tse,
Cindy Lo Kuen Lam
Publication year - 2019
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000573884.78506.aa
Subject(s) - medicine , metformin , hazard ratio , sulfonylurea , insulin , proportional hazards model , propensity score matching , type 2 diabetes , diabetes mellitus , retrospective cohort study , gastroenterology , endocrinology , confidence interval